Lupin, on 23 November, announced that it had received approval from the USFDA (United States Food and Drug Administration) for Canagliflozin Tablets, 100 mg and...
Lupin shares opened 1% above on 6 October after the company announced receiving tentative approval from USFDA ( the United States Food and Drug Administration)....
Lupin shares hit a 52-week high of Rs 1,184.70 on 29 September after the company received an Establishment Inspection Report for its Nagpur unit-I manufacturing...